Skip to main content
SpringerLink
Log in

Isotretinoin-Therapie: Wann, was, wie?

  • Conference paper
Book cover Fortschritte der praktischen Dermatologie und Venerologie

Part of the book series: Fortschritte der praktischen Dermatologie und Venerologie ((DERMATOLOGIE,volume 19))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alcalay J, Landau M, Zucker A (2001) Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests? J Dermatol Treat 12: 9–12

    Article  CAS  Google Scholar 

  2. Baxter KF, Ling TC, Barth JH, Cunliffe WJ (2003) Retrospective survey of serum lipids in patients receiving more than three courses of istoretinoin. J Dermatol Treat 14: 216–218

    Article  CAS  Google Scholar 

  3. Bickers DR, Saurat JH (2001) Isotretinoin: a state-of-the-art conference. J Am Acad Dermatol 45: 125–128

    Article  Google Scholar 

  4. Cunliffe WJ, van de Kerkhof PC, Caputo R, Caviccini S, Cooper A, Fyrand OL, Gollnick H, Layton AM, Leyden JJ, Mascaro JM, Ortonne JP, Shalita A (1997) Roaccutane treatment guidelines: results of an international survey. Dermatology 194: 351–357

    Article  CAS  PubMed  Google Scholar 

  5. Degitz K, Placzek M, Arnold B, Schmidt H, Plewig G (2001) Endokrinoloigsche Aspekte bei Akne. In: Plewig G, Degitz K (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie 2000. Bd 17. Springer, Berlin, S 172–179

    Chapter  Google Scholar 

  6. EMEA (2003) http://www.emea.eu.int/pdfs/human/refer-ral/isotretinoin/281103de1.pdf

    Google Scholar 

  7. EMEA (2003) http://www.emea.eu.int/pdfs/human/referral/isotretinoin/281103de.pdf

    Google Scholar 

  8. Ferahbas A, Turan MT, Esel E, Utas S, Kutlugun C, Kilic CG (2004) A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin. J Dermatol Treat 15: 153–175

    Article  CAS  Google Scholar 

  9. Geißler SE, Michelsen S, Plewig G (2003) Very low dose isotretinoin is effective in controlling seborrhoea. JDDG 1:952–958

    Article  PubMed  Google Scholar 

  10. Goldsmith LA, Bolognia JL, Callen JP, Chen SC, Feldman SR, Lim HW, Lucky AW, Reed BR, Siegfried EC, Thiboutot DM, Wheeland RG (2004) American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J Am Acad Dermatol 50: 900–906

    Article  PubMed  Google Scholar 

  11. Harms M, Duvanel T, Williamson C, Masouyé I, Saurat JH (1989) Isotretinoin for acne: should we consider the total cumulative dose? In: Marks R, Plewig G (eds) Acne and related disorders. Dunitz, London, pp 203–206

    Google Scholar 

  12. Hersom K, Neary MP, Levaux HP, Klaskala W, Strass JS (2003) Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis J Am Acad Dermatol 49: 424–433

    Article  PubMed  Google Scholar 

  13. Horting E, Paul E, Plewig G (1986) Treatment of rosacea with isotretinoin. Int J Dermatol 25: 660–663

    Article  Google Scholar 

  14. Jacobs DG, Deutsch NL, Brewer M (2001) Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 45: 168–175

    Article  Google Scholar 

  15. Jick SS, Kremers HM, Vasilakis-Scaramozza C (2000) Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 136: 1231–1236

    Article  CAS  PubMed  Google Scholar 

  16. Leyden JJ, McGinley KJ, Foglia AN (1986) Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. J Invest Dermatol 86: 390–393

    Article  CAS  PubMed  Google Scholar 

  17. Ling TC, Parkin G, Islam J, Seukeran DC, Cunliffe WJ (2001) What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH? Br J Dermatol 144: 630–632

    Article  CAS  PubMed  Google Scholar 

  18. Lowenstein EJ (2002) Isotretinoin made S.M.A.R.T.TM and simple. Cutis 70: 115–120

    PubMed  Google Scholar 

  19. Meigel WN (1997) How safe is isotretinoin? Dermatology 195: 22–28

    Article  PubMed  Google Scholar 

  20. Meigel WM (2003) Retinoide und Depression: Ein Zusammenhang? In: Plewig G, Prinz J (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie 2002. Bd 18. Springer, Berlin, S 214–217

    Chapter  Google Scholar 

  21. Nau H (2001) Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. J Am Acad Dermatol 45: 183–187

    Article  Google Scholar 

  22. Newton JN (1997) How cost-effective is oral isotretinoin? Dermatology 1951: 10–14

    Article  PubMed  Google Scholar 

  23. Palmer RA, Sidhu S, Googwin PG (2000) ‘Microdose’ isotretinoin. Br J Dermatol 143: 205–206

    Article  CAS  PubMed  Google Scholar 

  24. Plewig G (2003) Acne inversa, Acne keloidalis nuchae, abszedierende Follikulitis der Kopfhaut: Ein verbindendes Konzept. In: Plewig G, Prinz J (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie 2002. Bd 18. Springer, Berlin, S 192–203

    Chapter  Google Scholar 

  25. Plewig G, Dressel H, Pfleger M, Michelsen S, Kligman AM (2004) Low dose isotretinoin combined with tretinoin is effective to correct abnormalities of acne. JDDG 2: 31–45

    Article  PubMed  Google Scholar 

  26. Rohrback JM, Fleischer AB jr, Krowchuk DP, Feldman SR (2004) Depression is not common in isotretinoin-treated acne patients. J Dermatol Treat 15: 252

    Article  CAS  Google Scholar 

  27. Simon G (1848) Die Hautkrankheiten durch anatomische Untersuchungen erläutert. Reimer, Berlin

    Google Scholar 

  28. Weissmann A, Wagner A, Plewig G (1981) Reduction of bacterial skin flora during treatment of severe acne with 13-cis-retinoic acid. Arch Dermatol Res 270: 179–183

    Article  CAS  PubMed  Google Scholar 

  29. Wysowski DK, Beitz J (2001) Comments and opinions, methodological limitations of the study “Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide”. Arch Dermatol 137: 1102–1103

    CAS  PubMed  Google Scholar 

  30. Wysowski DK, Pitts M, Beiz J (2001) An analysis of reports of depression and suicide in patients treated with isotretinoin J Am Acad Dermatol 45: 515–519

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München, Frauenlobstraße 9-11, D-80337, München, Germany

    Gerd Plewig (Prof. Dr. med. Dr. h.c.)

Authors
  1. Gerd Plewig
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Gerd Plewig (Prof. Dr. med. Dr. h.c.)Peter Kaudewitz (Prof. Dr. med.)Christian A. Sander (Priv.-Doz. Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Plewig, G. (2005). Isotretinoin-Therapie: Wann, was, wie?. In: Plewig, G., Kaudewitz, P., Sander, C.A. (eds) Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28691-8_38

Download citation

  • DOI: https://doi.org/10.1007/3-540-28691-8_38

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21055-9

  • Online ISBN: 978-3-540-28691-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation